A citation-based method for searching scientific literature

David Posada. J Mol Evol 2015
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
66

Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE—.
Ken Yamaguchi, Kenichi Urakami, Keiichi Ohshima, Tohru Mochizuki, Yasuto Akiyama, Katsuhiko Uesaka, Takashi Nakajima, Mitsuru Takahashi, Sunao Tamai, Masatoshi Kusuhara. Biomed Res 2014
32
33

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
Andrea Sartore-Bianchi, Elena Ardini, Roberta Bosotti, Alessio Amatu, Emanuele Valtorta, Alessio Somaschini, Laura Raddrizzani, Laura Palmeri, Patrizia Banfi, Erica Bonazzina,[...]. J Natl Cancer Inst 2015
103
33

Mutational landscape and significance across 12 major cancer types.
Cyriac Kandoth, Michael D McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F McMichael, Matthew A Wyczalkowski,[...]. Nature 2013
33

Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
Rama Krishna Kancha, Nikolas von Bubnoff, Christian Peschel, Justus Duyster. Clin Cancer Res 2009
123
33

Beyond histology: translating tumor genotypes into clinically effective targeted therapies.
Catherine B Meador, Christine M Micheel, Mia A Levy, Christine M Lovly, Leora Horn, Jeremy L Warner, Douglas B Johnson, Zhongming Zhao, Ingrid A Anderson, Jeffrey A Sosman,[...]. Clin Cancer Res 2014
47
33

Targeting RTK Signaling Pathways in Cancer.
Tarik Regad. Cancers (Basel) 2015
204
33

Crystal structure of the tyrosine kinase domain of the human insulin receptor.
S R Hubbard, L Wei, L Ellis, W A Hendrickson. Nature 1994
915
33

Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
A Greco, C Miranda, M A Pierotti. Mol Cell Endocrinol 2010
124
33

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.
Nikhil Wagle, Michael F Berger, Matthew J Davis, Brendan Blumenstiel, Matthew Defelice, Panisa Pochanard, Matthew Ducar, Paul Van Hummelen, Laura E Macconaill, William C Hahn,[...]. Cancer Discov 2012
404
33

Two types of amino acid substitutions in protein evolution.
T Miyata, S Miyazawa, T Yasunaga. J Mol Evol 1979
321
33

EGFR mutation up-regulates EGR1 expression through the ERK pathway.
Mari Maegawa, Tokuzo Arao, Hideyuki Yokote, Kazuko Matsumoto, Kanae Kudo, Kaoru Tanaka, Hiroyasu Kaneda, Yoshihiko Fujita, Fumiaki Ito, Kazuto Nishio. Anticancer Res 2009
24
33

Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway.
B Wasylyk, J Hagman, A Gutierrez-Hartmann. Trends Biochem Sci 1998
430
33

Constitutive activating mutation of the FGFR3b in oral squamous cell carcinomas.
Yan Zhang, Yoshiko Hiraishi, Hua Wang, Ken-saku Sumi, Yasutaka Hayashido, Shigeaki Toratani, Mikio Kan, J Denry Sato, Tetsuji Okamoto. Int J Cancer 2005
44
33

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.
Y Yamamoto, H Kiyoi, Y Nakano, R Suzuki, Y Kodera, S Miyawaki, N Asou, K Kuriyama, F Yagasaki, C Shimazaki,[...]. Blood 2001
901
33

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
A Vaishnavi, M Capelletti, A T Le, S Kako, M Butaney, D Ercan, S Mahale, K D Davies, D L Aisner, A B Pilling,[...]. Nat Med 2013
399
33

Receptor tyrosine kinase inhibitors: Are they real tumor killers?
Andreas K A Gaumann, Friedemann Kiefer, Joachim Alfer, Sven A Lang, Edward K Geissler, Georg Breier. Int J Cancer 2016
22
33

Oncogenic ERBB3 mutations in human cancers.
Bijay S Jaiswal, Noelyn M Kljavin, Eric W Stawiski, Emily Chan, Chaitali Parikh, Steffen Durinck, Subhra Chaudhuri, Kanan Pujara, Joseph Guillory, Kyle A Edgar,[...]. Cancer Cell 2013
261
33

The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond.
Seth A Wander, Mark J Levis, Amir T Fathi. Ther Adv Hematol 2014
125
33

Tyrosine kinases as targets for cancer therapy.
Daniela S Krause, Richard A Van Etten. N Engl J Med 2005
981
33

Cancer genome landscapes.
Bert Vogelstein, Nickolas Papadopoulos, Victor E Velculescu, Shibin Zhou, Luis A Diaz, Kenneth W Kinzler. Science 2013
33




Lessons from the cancer genome.
Levi A Garraway, Eric S Lander. Cell 2013
802
33

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
Donavan T Cheng, Talia N Mitchell, Ahmet Zehir, Ronak H Shah, Ryma Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Yu Liu, Helen H Won, Sasinya N Scott,[...]. J Mol Diagn 2015
33

Molecular therapy for acute myeloid leukaemia.
Catherine C Coombs, Martin S Tallman, Ross L Levine. Nat Rev Clin Oncol 2016
79
33

Implementing personalized cancer genomics in clinical trials.
Richard Simon, Sameek Roychowdhury. Nat Rev Drug Discov 2013
202
33

Implementing personalized cancer care.
Richard L Schilsky. Nat Rev Clin Oncol 2014
56
33

Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors.
Guruprasad Ananda, Susan Mockus, Micaela Lundquist, Vanessa Spotlow, Al Simons, Talia Mitchell, Grace Stafford, Vivek Philip, Timothy Stearns, Anuj Srivastava,[...]. Exp Mol Pathol 2015
25
33

Integrative genomics viewer.
James T Robinson, Helga Thorvaldsdóttir, Wendy Winckler, Mitchell Guttman, Eric S Lander, Gad Getz, Jill P Mesirov. Nat Biotechnol 2011
33

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials.
Funda Meric-Bernstam, Lauren Brusco, Kenna Shaw, Chacha Horombe, Scott Kopetz, Michael A Davies, Mark Routbort, Sarina A Piha-Paul, Filip Janku, Naoto Ueno,[...]. J Clin Oncol 2015
293
33


Trk receptor expression and inhibition in neuroblastomas.
Garrett M Brodeur, Jane E Minturn, Ruth Ho, Anisha M Simpson, Radhika Iyer, Carly R Varela, Jennifer E Light, Venkatadri Kolla, Audrey E Evans. Clin Cancer Res 2009
202
33

Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers.
José M Correia da Costa, Nuno Vale, Maria J Gouveia, Mónica C Botelho, Banchob Sripa, Lúcio L Santos, Júlio H Santos, Gabriel Rinaldi, Paul J Brindley. Front Genet 2014
46
33

Genomic instability in complicated and uncomplicated Egyptian schistosomiasis haematobium patients.
Amany A Abd El-Aal, Ibrahim R Bayoumy, Maha M A Basyoni, Asmaa A Abd El-Aal, Ashraf M Emran, Magda S Abd El-Tawab, Manal A Badawi, Rabab M Zalat, Tarek M Diab. Mol Cytogenet 2015
8
33


Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.
Kern Rei Chng, Sock Hoai Chan, Amanda Hui Qi Ng, Chenhao Li, Apinya Jusakul, Denis Bertrand, Andreas Wilm, Su Pin Choo, Damien Meng Yew Tan, Kiat Hon Lim,[...]. EBioMedicine 2016
63
33

Chronic Opisthorchis viverrini Infection Changes the Liver Microbiome and Promotes Helicobacter Growth.
Upsornsawan Itthitaetrakool, Porntip Pinlaor, Somchai Pinlaor, Chariya Chomvarin, Rungtiwa Dangtakot, Apisit Chaidee, Chotechana Wilailuckana, Arunnee Sangka, Aroonlug Lulitanond, Puangrat Yongvanit. PLoS One 2016
25
33

A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development.
Pranee Sriraj, Thidarut Boonmars, Ratchadawan Aukkanimart, Jiraporn Songsri, Panupan Sripan, Panaratana Ratanasuwan, Sirintip Boonjaraspinyo, Nadchanan Wongchalee, Porntip Laummaunwai. Parasitol Res 2016
9
33

Parasite Infection, Carcinogenesis and Human Malignancy.
Hoang van Tong, Paul J Brindley, Christian G Meyer, Thirumalaisamy P Velavan. EBioMedicine 2017
59
33

Why does infection with some helminths cause cancer?
Paul J Brindley, José M Correia da Costa, Banchob Sripa. Trends Cancer 2015
60
33

The Schistosoma mansoni phylome: using evolutionary genomics to gain insight into a parasite's biology.
Larissa Lopes Silva, Marina Marcet-Houben, Laila Alves Nahum, Adhemar Zerlotini, Toni Gabaldón, Guilherme Oliveira. BMC Genomics 2012
26
33

The Leishmania metaphylome: a comprehensive survey of Leishmania protein phylogenetic relationships.
Hugo O Valdivia, Larissa L S Scholte, Guilherme Oliveira, Toni Gabaldón, Daniella C Bartholomeu. BMC Genomics 2015
16
33

Mechanisms of oxysterol-induced carcinogenesis.
Apinya Jusakul, Puangrat Yongvanit, Watcharin Loilome, Nisana Namwat, Rahul Kuver. Lipids Health Dis 2011
58
33

The role of evolutionary biology in research and control of liver flukes in Southeast Asia.
Pierre Echaubard, Banchob Sripa, Frank F Mallory, Bruce A Wilcox. Infect Genet Evol 2016
17
33

Assembling the lophotrochozoan (=spiralian) tree of life.
Gonzalo Giribet. Philos Trans R Soc Lond B Biol Sci 2008
71
33

Biological agents.
. IARC Monogr Eval Carcinog Risks Hum 2012
590
33

The bifacial role of helminths in cancer: involvement of immune and non-immune mechanisms.
Katerina Oikonomopoulou, Davor Brinc, Andreas Hadjisavvas, Georgios Christofi, Kyriacos Kyriacou, Eleftherios P Diamandis. Crit Rev Clin Lab Sci 2014
12
33

Oxidative stress-mediated mouse liver lesions caused by Clonorchis sinensis infection.
Sejung Maeng, Hye Won Lee, Qudsia Bashir, Tae Im Kim, Sung-Jong Hong, Tae Jin Lee, Woon-Mok Sohn, Byoung-Kuk Na, Tong-Soo Kim, Jhang Ho Pak. Int J Parasitol 2016
18
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.